Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Mar 3;36(1):25.
doi: 10.1186/s40880-017-0194-7.

Ailanthone: a new potential drug for castration-resistant prostate cancer

Shihong Peng  1 , Zhengfang Yi  2 , Mingyao Liu  3   4
Affiliations
Comment

Ailanthone: a new potential drug for castration-resistant prostate cancer

Shihong Peng et al. Chin J Cancer. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi: 10.3322/caac.21254. - DOI - PubMed
    1. Chen W, Zheng R, Zeng H, Zhang S. The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer. 2015;34(11):502–507. - PMC - PubMed
    1. Dutt SS, Gao AC. Molecular mechanisms of castration-resistant prostate cancer progression. Future Oncol (London, England) 2009;5(9):1403–1413. doi: 10.2217/fon.09.117. - DOI - PMC - PubMed
    1. Sun S, Sprenger CC, Vessella RL, Haugk K, Soriano K, Mostaghel EA, et al. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant. J Clin Investig. 2010;120(8):2715–2730. doi: 10.1172/JCI41824. - DOI - PMC - PubMed
    1. Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med. 2014;371(11):1028–1038. doi: 10.1056/NEJMoa1315815. - DOI - PMC - PubMed

Publication types